Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg Under Fasting Conditions
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare and evaluate the single-dose oral bioavailability
of the test formulation of Sertraline Hydrochloride 100 mg tablets (Dr. Reddy's Laboratories
Limited) with the reference formulation ZOLOFT® 100 mg Tablet (Pfizer)under fasting
conditions in healthy adult human subjects.